BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15378017)

  • 1. Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice.
    Martín-Caballero J; Flores JM; García-Palencia P; Collado M; Serrano M
    Oncogene; 2004 Oct; 23(50):8231-7. PubMed ID: 15378017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
    Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
    Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
    Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
    Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J; Fried M
    Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.
    Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ
    Oncogene; 2004 Jan; 23(4):905-13. PubMed ID: 14647411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
    Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
    Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing roles for p21(waf1/cip1) and p27(kip1) in enterocyte differentiation, proliferation, and migration.
    Stehr W; Mercer TI; Bernal NP; Erwin CR; Warner BW
    Surgery; 2005 Aug; 138(2):187-94. PubMed ID: 16153426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
    IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
    DeInnocentes P; Agarwal P; Bird RC
    J Cell Biochem; 2009 Feb; 106(3):491-505. PubMed ID: 19130492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
    Matheu A; Pantoja C; Efeyan A; Criado LM; Martín-Caballero J; Flores JM; Klatt P; Serrano M
    Genes Dev; 2004 Nov; 18(22):2736-46. PubMed ID: 15520276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
    Hemmati PG; Normand G; Verdoodt B; von Haefen C; Hasenjäger A; Güner D; Wendt J; Dörken B; Daniel PT
    Oncogene; 2005 Jun; 24(25):4114-28. PubMed ID: 15750619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of p27kip1 and increased hepatocyte proliferation in p53-deficient mice.
    Yang C; Sun M; Ilic Z; Friedrich TD; Sell S
    Mol Carcinog; 2003 Jan; 36(1):15-22. PubMed ID: 12503075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
    Damo LA; Snyder PW; Franklin DS
    Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development.
    Carneiro C; Jiao MS; Hu M; Shaffer D; Park M; Pandolfi PP; Cordon-Cardo C; Koff A
    Oncogene; 2003 Jan; 22(3):361-9. PubMed ID: 12545157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectral karyotyping of sarcomas and fibroblasts derived from Ink4a/Arf-deficient mice reveals chromosomal instability in vitro.
    Robertson SA; Schoumans J; Looyenga BD; Yuhas JA; Zylstra CR; Koeman JM; Swiatek PJ; Teh BT; Williams BO
    Int J Oncol; 2005 Mar; 26(3):629-34. PubMed ID: 15703817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.